Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Trust and Equitable Access: What Good is a COVID-19 Vaccine if Few Get It?

Trust and Equitable Access: What Good is a COVID-19 Vaccine if Few Get It?

December 9 at 1:30 pm PT/4:30 pm ET

With a number of promising COVID-19 vaccine candidates in clinical trials, hopes for a safe and effective vaccine are rising. This raises a new set of challenges. How and where do we ramp up manufacturing capacity (vaccines, glass vials, etc.)? How do we manage the equitable distribution of it to billions of people? Perhaps most crucially, how do we foster public trust with diverse communities, many of them underserved and high-risk, and convince them that immunization is safe and effective? Finally, even once these steps have been taken, will "vaccine nationalism" undermine our best-laid plans?


Helene Gayle
President and CEO, The Chicago Community Trust; Co-Chair, National Academies Committee on Equitable Allocation of a COVID-19 Vaccine

Aboubacar Kampo
Director of Health Programmes, UNICEF

Heidi Larson
Director, The Vaccine Confidence Project; Professor, Anthropology and Risk, London School of Hygiene & Tropical Medicine

Peter Sands
Executive Director, The Global Fund to fight Aids, Tuberculosis and Malaria


Rick Berke
Co-Founder and Executive Editor, STAT

See Also

COVID-19 Vaccine Tracker and Visualization